Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220031 · ClinicalTrials.gov registry record
Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Not yet
- Registry status
- 8
- Enrollment target
NCT07220031: Clinical Trial study, sponsored by State University of New York - Upstate Medical University.
NCT07220031 is a clinical trial that has not yet begun recruiting, run by State University of New York - Upstate Medical University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07220031 has not yet begun recruiting, sponsored by State University of New York - Upstate Medical University.
- NOT YET RECRUITING
- Registry status
- 8 participants
- Enrollment target
Study Summary
The goal of this observational study is to determine whether a clinically relevant dose of activated charcoal raises the serum osmolality and osmolal gap in a population of healthy volunteers. Secondarily to determine whether the same dose creates a false positive result using an enzymatic assay. 1. Does a clinically relevant dose of commercially available activated charcoal raise the osmolal gap above the baseline of a healthy volunteer? 2. Does the same dose of charcoal cause a false positive enzymatic assay for ethylene glycol? Participants will be asked to consume a dose of activated charcoal and have serial blood draws for laboratory measurements.
Primary Outcome
Delta serum osmolality and osmolal gap at time points 0.5, 1, 2, 4, and 6 hours after Activated charcoal given
Interventions
- DRUG Activated Charcoal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2025-11-15 |
| Est. Completion | 2026-05-01 |
What is known before NCT07220031 opens enrollment
NCT07220031 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Activated Charcoal is the first listed.
NCT07220031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07220031 about?
NCT07220031 is a clinical study titled "Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay". The goal of this observational study is to determine whether a clinically relevant dose of activated charcoal raises the serum osmolality and osmolal gap in a population of healthy volunteers. Secondarily to determine whether the same dose creates a false positive result using an enzymatic assay. 1...
What is the current status of trial NCT07220031?
This trial is currently not yet recruiting. The enrollment target is 8 participants. The study started on 2025-11-15. Estimated completion is 2026-05-01.
What interventions are being tested in trial NCT07220031?
The interventions under investigation include: Activated Charcoal (DRUG).
Who is sponsoring clinical trial NCT07220031?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI